JPH0473416B2 - - Google Patents
Info
- Publication number
- JPH0473416B2 JPH0473416B2 JP60169216A JP16921685A JPH0473416B2 JP H0473416 B2 JPH0473416 B2 JP H0473416B2 JP 60169216 A JP60169216 A JP 60169216A JP 16921685 A JP16921685 A JP 16921685A JP H0473416 B2 JPH0473416 B2 JP H0473416B2
- Authority
- JP
- Japan
- Prior art keywords
- eel
- gill disease
- administration
- leaves
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 201000010099 disease Diseases 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 12
- 240000006891 Artemisia vulgaris Species 0.000 claims description 12
- 239000002075 main ingredient Substances 0.000 claims description 2
- 230000003449 preventive effect Effects 0.000 claims description 2
- 229940126585 therapeutic drug Drugs 0.000 claims 1
- 210000002816 gill Anatomy 0.000 description 15
- 239000000843 powder Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 241000252073 Anguilliformes Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229930004725 sesquiterpene Natural products 0.000 description 2
- IMWCPTKSESEZCL-SPSNFJOYSA-H (e)-but-2-enedioate;iron(3+) Chemical compound [Fe+3].[Fe+3].[O-]C(=O)\C=C\C([O-])=O.[O-]C(=O)\C=C\C([O-])=O.[O-]C(=O)\C=C\C([O-])=O IMWCPTKSESEZCL-SPSNFJOYSA-H 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N 3‐isothujone Chemical compound CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 241000638253 Artemisia montana Species 0.000 description 1
- 235000004356 Artemisia montana Nutrition 0.000 description 1
- 235000017519 Artemisia princeps Nutrition 0.000 description 1
- 244000065027 Artemisia princeps Species 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 1
- 241000863434 Myxococcales Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- -1 sesquiterpene alcohols Chemical class 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229930007110 thujone Natural products 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60169216A JPS6229530A (ja) | 1985-07-31 | 1985-07-31 | ウナギの鰓病薬 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60169216A JPS6229530A (ja) | 1985-07-31 | 1985-07-31 | ウナギの鰓病薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6229530A JPS6229530A (ja) | 1987-02-07 |
| JPH0473416B2 true JPH0473416B2 (enExample) | 1992-11-20 |
Family
ID=15882363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60169216A Granted JPS6229530A (ja) | 1985-07-31 | 1985-07-31 | ウナギの鰓病薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6229530A (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2779698B2 (ja) * | 1990-08-07 | 1998-07-23 | 本田技研工業株式会社 | 自動二輪車のカウリングおよびその製造方法 |
| ATE431080T1 (de) * | 1999-10-13 | 2009-05-15 | Ewos Ltd | Fischfutter mit erhöhtem gehalt an nukleotiden |
-
1985
- 1985-07-31 JP JP60169216A patent/JPS6229530A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6229530A (ja) | 1987-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0279382B1 (de) | Warzenmittel | |
| DE69328558T2 (de) | Pharmazeutisches Präparat zur synergistischen Aktivierung natürlicher Killerzellen | |
| JP4700808B2 (ja) | フルボ酸、および種々の状態の処置におけるその使用 | |
| DE3328262A1 (de) | Arzneimittelzubereitung zur besserung von krebssymptomen | |
| JPS62240619A (ja) | 制癌剤 | |
| KR20120046795A (ko) | 신경퇴행성 또는 신경근 퇴행성 질환의 치료 방법 및 이러한 질환들을 치료하기 위한 치료제 | |
| JPS62501360A (ja) | 製薬学的に活性な化合物を含有する病気治療剤 | |
| DE69232911T2 (de) | Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen | |
| Siveen et al. | Augmentation of humoral and cell mediated immune responses by Thujone | |
| US2721161A (en) | Ascorbic acid preparation | |
| US4346082A (en) | Method of employing therapeutic composition comprising ammonium or substituted ammonium compounds for treatment of alcoholism | |
| JPH0473416B2 (enExample) | ||
| Hewitt et al. | The treatment of ascariasis in dogs with 1-diethylcarbamyl-4-methylpiperazine hydrochloride | |
| JPH07223940A (ja) | 活性酸素消去剤及びこれを含有する組成物 | |
| DE3153623C2 (enExample) | ||
| Koletsky et al. | Effect of antibiotics on mortality from internal radiation. | |
| DE19815411A1 (de) | Thermogenese stimulierend wirksame Arzneimittel | |
| JPS62221633A (ja) | アユの鰓病薬 | |
| Bambhole | Effect of some medicinal plant preparations of adipose tissue metabolism | |
| EP0372676A1 (en) | Therapeutic preparation and method | |
| OUEDRAOGO et al. | Toxicity assessment of a phytomedicine based on an almond extract from the fruit of Balanites aegyptiaca (L.) DELILE (Zygophyllaceae) intended for helminthiases care in Burkina Faso. | |
| Beasley | The druggist's general receipt book | |
| JPS5984826A (ja) | 動物の育毛促進方法 | |
| KR0142809B1 (ko) | 간질환 치료용 약제조성물 | |
| RU1826910C (ru) | Биостимулирующее средство |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |